Product
Interleukin-4 receptor
1 clinical trial
1 indication
Indication
Allergic RhinitisClinical trial
The Efficacy and Safety of Humanized Antibody Targeting the Interleukin-4 Receptor Alpha Subunit (IL-4Rα) in Patients With Uncontrolled Seasonal Allergic Rhinitis Under Standard Treatment： A Randomized, Double-Blind, Placebo-controlled IIT StudyStatus: Not yet recruiting, Estimated PCD: 2025-05-30